Use of varenicline for smoking cessation treatment in UK primary care: An association rule mining analysis

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Huang, Yue ^a   Lewis, Sarah ^a   Britton, John ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Associate rule mining; Primary care data; Smoking cessation; Varenicline

Indexed keywords

BENZAZEPINE DERIVATIVE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE; VARENICLINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; FACTUAL DATABASE; FEMALE; HUMAN; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROCEDURES; SEXISM; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BENZAZEPINES; DATABASES, FACTUAL; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; PRIMARY HEALTH CARE; QUINOXALINES; SEXISM; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908015557     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-1024     Document Type: Article

References (22)

1. Smoking statistics: who smokes and how much. Action on Smoking and Health (ASH), 2013 http://ash.org.uk/files/documents/ASH-106.pdf
2. The delivery of smoking cessation interventions to primary care with mental health problems. Szatkowski L, McNeil A, Addiction 2013 108 1487 1494 doi:10.1111/add.12163 10.1111/add.12163 23534846
3. Statistics on smoking: England 2012. The NHS Information Centre for Health and Social Care, 2012 http://www.hscic.gov.uk/catalogue/PUB07019/smok-eng-2012-rep.pdf
4. Smoking cessation therapy with varenicline. Mohanasundaram UM, Chitkara R, Krishna G, International Journal of Chronic Obstructive Pulmonary Disease 2008 3 2 239 251 18686733
5. Nicotine receptor partial agonists for smoking cessation (Review). Cahill K, Stead LF, Lancaster T, The Cochrane Collaboration 2012 doi:10.1002/14651858.CD006103.pub6
6. National Institute for Health and Care Excellence (NICE), Guidance on smoking cessation (PH10) London: NICE 2008 http://www.nice.org.uk/guidance/ph10/resources/guidance-smoking-cessation-services-pdf
7. Prescribing of smoking cessation medication in England since the introduction of varenicline. Langley TE, Huang Y, McNeill A, Coleman T, Szatkowski L, Lewis S, Addiction 2011 106 1319 1324 doi:10.1111/j.1360-0443.2011.03426.xi 10.1111/j.1360-0443.2011.03426.x 21395894
8. Varenicline: a first-line treatment option for smoking cessation. Garrison GD, Dugan SE, Clin Ther 2009 3 3 463 490
9. Who receives prescriptions for smoking cessation medication? An association rule mining analysis using a large primary care database. Huang Y, Britton J, Hubbard R, Lewis S, Tob Control 2013 22 274 279 doi:10.1136/tobaccocontrol-2011-050124 10.1136/tobaccocontrol-2011-050124 22246781
10. The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care records: cross-sectional analyses from The Health Improvement Network (THIN) database. Taggar JS, Coleman T, Lewis S, Szatkowski L, BMC Public Health 2012 12 329 doi:10.1186/1471-2458-12-329 10.1186/1471-2458-12-329 22559290
11. Witten IH, Frank E, Data Mining: Practical Machine Learning Tools and Techniques (2nd ed) Burlington, Massachusetts: Morgan Kaufmann 2005
12. Royal College of Physicians & Royal College of Psychiatrists, Smoking and mental health London: RCP 2013 https://www.rcplondon.ac.uk/sites/default/files/smoking-and-mental-health-full-report-web.pdf
13. Change in mental health after smoking cessation: systematic review and meta-analysis. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P, BMJ 2014 384 1151 doi:10.1136/bmj.g1151
14. The impact of smoking cessation on schizophrenia and major depression. Ragg M, Gordon R, Ahmed T, Allan J, Australasian Psychiatry 2013 21 3 238 245 doi:10.1177/1039856213486213 10.1177/1039856213486213 23616382
15. National Institute for Health and Care Excellence (NICE), Dementia-Supporting people with dementia and their carers in health and social care (CG42) London: NICE 2006 http://www.nice.org.uk/guidance/cg42/resources/guidance-dementia-pdf
16. National Institute for Health and Care Excellence (NICE), Smoking cessation in secondary care: acute, maternity and mental health services (PH48) London: NICE 2013 http://www.nice.org.uk/guidance/ph48/resources/guidance-smoking-cessation-in-secondary-care-acute-maternity-and-mental-health-services-pdf
17. U.S. Food and Drug Administration (FDA), Information for Healthcare Professionals: Varenicline (marked as Chantix) and Bupropion (marked as Zyban, Wellbutrin, and generics) 2009 http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm170090.htm, Published July 1, 2009. Updated August 15, 2013
18. British National Formulary (BNF), Varenicline 2007 http://www.bnf.org/bnf/go?bnf/current/PHP3207-varenicline.htm
19. Smoking cessation treatment and risk of depression, suicide, and self-harm in the Clinical Practice Research Datalink: prospective cohort study. Thomas KH, Martin RM, Davies NM, Metcalfe C, Windmeijer F, Gunnell D, BMJ 2013 347 15704 doi:10.1136/bmj.f5704
20. Effects of varenicline on smoking cessation in audlts with stably treated current or past major depression. Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, Russ C, Yunis C, Ann Intern Med 2013 159 390 400 10.7326/0003-4819-159-6-201309170-00005 24042367
21. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder. Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, Achtyes ED, Ayer D, Schoenfeld DA, JAMA 2014 311 2 145 154 doi:10.1001/jama.2013.285113 10.1001/jama.2013.285113 24399553
22. Smoking, dementia and cognitive decline in the elderly, a systematic review. Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpott C, BMC Geriatr 2008 8 36 doi:10.1186/1471-2318-8-36 10.1186/1471-2318-8-36 19105840